Altrius Capital Management Inc lowered its stake in Eaton Co. plc (NYSE:ETN – Free Report) by 3.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,368 shares of the industrial products company’s stock after selling 1,302 shares during the quarter. Eaton accounts […]
Abbrea Capital LLC lowered its stake in shares of Medtronic plc (NYSE:MDT – Free Report) by 19.9% in the fourth quarter, HoldingsChannel reports. The firm owned 4,952 shares of the medical technology company’s stock after selling 1,230 shares during the quarter. Abbrea Capital LLC’s holdings in Medtronic were worth $411,000 as of its most recent […]
Investment House LLC decreased its position in shares of Accenture plc (NYSE:ACN – Free Report) by 0.7% in the 4th quarter, Holdings Channel reports. The fund owned 91,315 shares of the information technology services provider’s stock after selling 603 shares during the quarter. Accenture accounts for approximately 2.3% of Investment House LLC’s holdings, making the […]
Syon Capital LLC increased its position in shares of National Grid plc (NYSE:NGG – Free Report) by 32.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,556 shares of the utilities provider’s stock after buying an additional 3,342 shares during the period. Syon […]
Schnieders Capital Management LLC trimmed its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 8.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 550 shares of the insurance provider’s stock after selling 50 shares during the period. […]
Bfsg LLC lowered its stake in shares of Roper Technologies, Inc. (NYSE:ROP – Free Report) by 1.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,674 shares of the industrial products company’s stock after selling 42 shares during the period. Bfsg […]
Savant Capital LLC trimmed its stake in shares of General Electric (NYSE:GE – Free Report) by 9.8% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 24,358 shares of the conglomerate’s stock after selling 2,654 shares during the period. Savant Capital LLC’s holdings in General Electric were […]
MCF Advisors LLC trimmed its position in Tyler Technologies, Inc. (NYSE:TYL – Free Report) by 2.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,391 shares of the technology company’s stock after selling 108 shares during the quarter. […]
Victory Capital Management Inc. cut its holdings in shares of Salesforce, Inc. (NYSE:CRM – Free Report) by 1.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 636,183 shares of the CRM provider’s stock after selling 11,714 shares during the quarter. Victory […]
Fisher Asset Management LLC increased its stake in shares of Shell plc (NYSE:SHEL – Free Report) by 2.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,871,131 shares of the energy company’s stock after acquiring an additional 477,432 shares during the quarter. Fisher Asset […]
Orca Investment Management LLC lessened its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 37,400 shares of the biopharmaceutical company’s stock after selling 908 shares during the quarter. Bristol-Myers Squibb makes […]
Abbrea Capital LLC decreased its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,962 shares of the medical research company’s stock after selling 47 shares during the period. Abbrea Capital LLC’s […]